In this SOHO Insider roundtable discussion, Charalambos (Babis) Andreadis, MD, MS, professor of clinical medicine at University of California, San Francisco, moderates a discussion on CELLMods in lymphoma.
The panelists include Jason Westin, MD, associate professor in the Department of Lymphoma/Myeloma at University of Texas MD Anderson Cancer Center; Loretta Nastoupil, MD, section chief of indolent lymphoma and director of clinical research at Common Spirit Health; and Swetha Thiruvengadam, MD, assistant clinical professor in the Department of Hematology & Hematopoietic Cell Transplantation at City of Hope.
In this video, the group discusses approaching frontline follicular lymphoma patients, including determining patients who are high risk using symptoms and extent of disease.
“We need more predictive markers at the time of diagnosis to really tailor the therapies… But how aggressively to treat really depends on symptoms and disease extent,” Dr. Thiruvengadam said.
Watch more videos from this discussion.
This video is being brought to you by an education grant by Bristol Myers Squibb.
